Ignite Creation Date:
2024-05-06 @ 9:44 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03065764
Status:
UNKNOWN
Last Update Posted:
2017-08-17
First Post:
2017-01-20
Brief Title:
89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer
Sponsor:
Amsterdam UMC location VUmc
Organization:
Amsterdam UMC location VUmc
Organization Data
Organization:
Amsterdam UMC location VUmc
Class:
OTHER
Study ID:
PN221
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amsterdam UMC location VUmc
Lead Sponsor Class:
OTHER
Responsible Party:
Prof dr EF Smit
Responsible Party Title:
Prof dr EF Smit Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Amsterdam UMC location VUmc
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |